Curb your marketing
This article was originally published in The Tan Sheet
Weight-loss patch manufacturer Curb Your Cravings should discontinue its marketing claims until "reliable and competent" testing is conducted on the product, the Electronic Retailing Self-Regulation Program recommends. The Council of Better Business Bureaus subsidiary took issue with the company's emails and online ads that included claims such as "lose up to 30 pounds in 30 days" and "put on the Patch, take off the pounds." Curb Your Cravings' claims were brought to ERSP's attention by a consumer complaint. The company disagrees with ERSP's decision, but "will modify its advertising and discontinue the use of the general performance claims," the firm states...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”